All News

The Biden administration announced efforts to boost COVID-19 vaccination supply and increase transparency.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Here's the roundup of the latest coronavirus-related news.

Alliance will provide insight, education, and training opportunities to pharmaceutical and life sciences professionals.

In its next live webinar event, MJH Life Sciences™ COVID-19 Coalition will explore emerging mutations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Apart from COVID-19, there are several other industry trends taking root that will likely have a transformative effect on the profession in years to come.

Users of the PrimeRx pharmacy management technology system now have direct integration access to Surescripts Real-Time Prescription Benefit.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

President-elect Joe Biden revealed his COVID-19 plan, which includes a disciplined focus on vaccination efforts.

In a final briefing, OWS recommended states expand vaccination to all individuals 65 and older or those with comorbidities.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

The FDA has identified 3 molecular tests that may be impacted by an emerging SARS-CoV-2 variant.

AmerisourceBergen has announced its acquisition of the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses.

In a statement, FDA officials recommended that all health care professionals continue to adhere to the FDA-authorized dosing and schedules of the COVID-19 vaccines.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

With support from Operation Warp Speed and the National Institutes of Health, the study will evaluate the safety and efficacy of NVX-CoV2373.

Here are some of the top-read FDA approvals covered by Drug Topics® from this year.

The Drug Topics® team rounded up some of our top-read articles from the last year.

Here’s the last roundup of the latest coronavirus-related news in 2020.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event on the disproportionate impact of COVID-19 among racial and ethnic minority groups.

The FDA approved ansuvimab-zykl (Ebanga; Ridgeback Biotherapeutics) for the treatment of Zaire ebolavirus (Ebolavirus) infection in adults and children.

Pharmacists can now access this on-demand webcast for insights on how to optimize their business through in-store experience, marketing, managed care, and business performance.

The FDA has authorized the Moderna mRNA vaccine for emergency use, making it the second vaccine for COVID-19.

Extra vaccine multidose vials may boost the country’s supply by millions of doses.

Here’s a roundup of the latest coronavirus-related news.

US prescription opioid use dropped 60% from its peak volume in 2011, according to a new report from the IQVIA Institute for Human Data Science.

This week, members of the MJH Life Sciences COVID-19 Coalition shared insights on the latest pandemic news, including long-term health consequences, vaccine hesitancy, and new recommendations.

The program is designed to provide immunization administration training to hundreds of thousands of pharmacy technicians within weeks.